Pilot Therapeutics Holdings Inc.

OTCPK:PLTT Stock Report

Market Cap: US$1.2k

Pilot Therapeutics Holdings Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Ross Consaul

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure16.3yrs
CEO ownershipn/a
Management average tenure19.5yrs
Board average tenure23.7yrs

Recent management updates

No updates

Recent updates

No updates

CEO

Ross Consaul

16.3yrs

Tenure

Mr. Ross Consaul has been Chief Executive Officer of Pilot Therapeutics Holdings Inc. since October 2007.

Leadership Team

NamePositionTenureCompensationOwnership
John Crain
Vice President of Sales22yrsUS$122.00kno data
Ross Consaul
Chief Executive Officer16.3yrsno datano data
Keith Wakeman
President16.3yrsno datano data
Steven Greenberg
Chief Financial Officer19.5yrsno datano data
Scott Derks
Chief Operating Officerno datano datano data
Glenn Kline
Secretary and Director20.9yrsno datano data

19.5yrs

Average Tenure

Experienced Management: PLTT's management team is seasoned and experienced (19.5 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Glenn Kline
Secretary and Director25.4yrsno datano data
Margaret Urquhart
Director22.8yrsno datano data
James Johnston
Director24.7yrsno datano data
Bradley Undem
Director25yrsno datano data
Terrance Little
Chairman19.5yrsno datano data
Thomas Glennon
Director19.5yrsno datano data

23.7yrs

Average Tenure

69.5yo

Average Age

Experienced Board: PLTT's board of directors are seasoned and experienced ( 23.7 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/01/24 05:38
End of Day Share Price 2023/10/27 00:00
Earnings2003/06/30
Annual Earnings2002/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Pilot Therapeutics Holdings Inc. is covered by 0 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.